In a correlative study using a subset of tumour samples from EORTC 22981/26981 by Hegi et al (2005), median survival was significantly improved in those patients treated with temozolomide in whom tumour MGMT was inactivated by hypermethylation of CpG islands in the promoter region. Here, MGMT is linked to neoplasm.